Application no. and date | 15701861.5 (espacenet) (Federated) (European Patent Register), 20150107 | Patent/reg. no. and date | DK/EP 3094322, 20200408 | Publication date | 20161123 | Priority no. and date | US 201461927465 P, 20140114, US 201414511669, 20141010 | EP pub. no. and date |
EP 3094322 20161123 | Effective date | | Applicant/owner | Vanda Pharmaceuticals Inc., 2200 Pennsylvania Ave NW Suite 300-E
Washington, DC 20037, US | Applicant ref. no. | 1542960 | Inventor | DRESSMAN, Marlene, Michelle, 18005 Red Rocks Drive
Germantown, MD 20874, US, POLYMEROPOULOS, Mihael, H., 10627 Rivers Bend Lane
Potomac, MD 20854, US, BAROLDI, Paolo, 2200 Pennsylvania Avenue
Washington, DC 20037, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/343 (2006.01) , A61P 25/00 (2006.01) , A61P 43/00 (2006.01) | Title | ADMINISTRATION AF TASIMELTEON I FASTENDE TILSTAND | Int. application no. | US2015010410 | Int. publication no. | WO2015108728 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|